Viking Therapeutics, Inc.
Overview
Viking Therapeutics, Inc. is a biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidates target conditions such as non-alcoholic steatohepatitis (NASH) and X-linked adrenoleukodystrophy (X-ALD).
Therapeutic areas
Metabolic DisordersEndocrine Disorders
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Viking Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.